New registered manufacturer is publicly announced

in page functions

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate

Geneva, 30 September 2009 - Panacea Biotect Ltd and the Serum institute of India are two of the companies that have begun the registration process in order to participate. Several companies have inquired about the pilot.

Information about the number and names of manufacturers is confidential unless a firm requests its information to be made public.

For more information about the AMC registration process please contact: amc@gavi.org 

>100 million

Since 2011, Gavi-supported yellow fever campaigns have protected over 98 million people in 14 countries. We have also helped 17 countries introduce yellow fever vaccine through routine immunisation, immunising more than 100 million children.

Gavi

More facts...

close icon

modal window here